Stock to buy today: CESC (₹148) – BUY
[ad_1] The short-term outlook is bullish for CESC. The stock has formed an inverted head and shoulder reversal pattern. Wednesday’s 4 per cent rise has
Stock Market Live Updates 20 March 2025: Stock to buy today: CESC (₹148) – BUY
[ad_1] Sensex, Nifty Live updates on 20th March 2025: The short-term outlook is bullish for CESC. The stock has formed an inverted head and shoulder
Apollo to buy UK energy services group as investors bet on demand for power
[ad_1] Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. US investment giant Apollo
Sensex Nifty Today, Stock Market LIVE Updates: Stock to buy today: Indian Hotels Company (₹785.60) – BUY
[ad_1] tock Market Today | Share Market Live Updates – Find here all the live updates related to Sensex, Nifty, BSE, NSE, share prices and
Stock to buy today: Indian Hotels Company (₹785.60) – BUY
[ad_1] The short-term outlook is bullish for Indian Hotels Company. The stock has surged over 4 per cent on Tuesday and has closed on a
Will anybody buy a ‘Mar-a-Lago accord’?
[ad_1] The US president wants both to protect domestic manufacturing and hold the dollar as the reserve currency [ad_2] Source link
Stock to buy today: Bikaji Foods International (₹683.25)
[ad_1] The stock of Bikaji Foods International, which has been in a downtrend between October last year and February this year, found a base at
Stock Market Live Updates 18 March 2025: Stock to buy today: Bikaji Foods International (₹683.25)
[ad_1] Sensex, Nifty Live updates on 18th March 2025: The stock of Bikaji Foods International, which has been in a downtrend between October last year
Google parent Alphabet in talks to buy cyber security group Wiz for $30bn
[ad_1] Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Google parent Alphabet is
AstraZeneca to buy EsoBiotec for up to $1 billion
[ad_1] AstraZeneca Plc, the UK drugmaker, agreed to buy the Belgian biotech EsoBiotec for as much as $1 billion to further boost its cancer capabilities.
